Advanced Pharmacist - Haematopoietic Stem cell transplantation (HSCT)

The post holder leads, delivers, develops, manages and evaluates the clinical pharmacy services for HSCT unit. Acts as named lead and retain responsibility for the operational management and oversight of the HSCT unit To work closely with ATMP pharmacist to safely implement the introduction and use of ATMPs, e.g. CAR-T cell therapy for haematological malignancies. To work closely with the Haematology pharmacist in the service with the view to maintain an overview of the activities of permanent and rotational staff in the pharmacy team, to ensure adequate cover for the provision of pharmacy services across Haematology directorate. Working for your organisation

You will deliver and develop pharmacy services to cancer patients and in particular, Haematology and Hematopoietic Stem Cell Transplantation (HSCT). You will be supported by our CMG lead pharmacists, Consultant Pharmacist Haematology and newly appointed principal pharmacist in Advanced Therapy Medicinal Products (ATMPs). UHL is committed to the development of Consultant Pharmacy practice, with five consultants in post, including Haematology and Oncology & Clinical Trials. If you are a prescriber you will have the opportunity to undertake clinics within a specific area. Our Cancer Centre, based at the Leicester Royal Infirmary site serves a population of over 1 million and is at the forefront of research and clinical innovation; incorporating a Phase I trials unit, Stem Cell Transplant Unit and commissioned CAR-T service. We have 73 in-patient beds across Oncology, Haematology and Palliative care. We work with partners at the University of Leicester and De Montfort University to deliver world-class teaching. The newly launched, Institute for Excellence in Healthcare (IEH), a collaboration between University Hospitals of Leicester NHS Trust (UHL) and University of Leicester (UoL) will deliver world-class research opportunities for healthcare colleagues in Leicester, Leicestershire and Rutland, boosting your access to clinical fellowships and fostering a research culture which embeds research in day-to-day clinical practice., Our new strategy, developed with the support and feedback of colleagues, patients, and partners, is our compass for the next seven years (2023-2030). We have four primary goals:

• high-quality care for all,
• being a great place to work,
• partnerships for impact, and
• research and education excellence
And we will embed health equality in all we do - taking active steps to reduce the avoidable differences in healthcare that some people face, working in partnership with communities. Our strategy is underpinned by new values and we will work to ensure they are an everyday reality for all:
• we are compassionate,
• we are proud,
• we are inclusive, and
• we are one team
This is an exciting moment as we look to the future with clarity on what we already do well and where we need to focus our energies to make an even bigger difference for the people we serve.